Chem Shift validation: AVS_anomalous, AVS_full, LACS
BMRB Entry DOI: doi:10.13018/BMR26648
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Krishnarjuna, Bankala; Lim, San Sui; Devine, Shane; Debono, Cael; Lam, Raymond; Chandrashekaran, Indu; Jaipuria, Garima; Yagi, Hiromasa; Atreya, Hanudatta; Scanlon, Martin; MacRaild, Christopher; Scammells, Peter; Norton, Raymond. "Solution NMR characterization of apical membrane antigen 1 and small molecule interactions as a basis for designing new antimalarials" J. Mol. Recognit. 29, 281-291 (2016).
PubMed: 26804042
Assembly members:
FVO_PfAMA1, polymer, 335 residues, Formula weight is not available
Natural source: Common Name: malaria parasite P. falciparum Taxonomy ID: 5833 Superkingdom: Eukaryota Kingdom: not available Genus/species: Plasmodium falciparum
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pPROEX HTb
Data type | Count |
13C chemical shifts | 403 |
15N chemical shifts | 218 |
1H chemical shifts | 218 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | Hydrophobic cleft | 1 |
Entity 1, Hydrophobic cleft 335 residues - Formula weight is not available
1 | ASN | TYR | MET | GLY | ASN | PRO | TRP | THR | GLU | TYR | ||||
2 | MET | ALA | LYS | TYR | ASP | ILE | GLU | GLU | VAL | HIS | ||||
3 | GLY | SER | GLY | ILE | ARG | VAL | ASP | LEU | GLY | GLU | ||||
4 | ASP | ALA | GLU | VAL | ALA | GLY | THR | GLN | TYR | ARG | ||||
5 | LEU | PRO | SER | GLY | LYS | CYS | PRO | VAL | PHE | GLY | ||||
6 | LYS | GLY | ILE | ILE | ILE | GLU | ASN | SER | ASN | THR | ||||
7 | THR | PHE | LEU | LYS | PRO | VAL | ALA | THR | GLY | ASN | ||||
8 | GLN | ASP | LEU | LYS | ASP | GLY | GLY | PHE | ALA | PHE | ||||
9 | PRO | PRO | THR | ASN | PRO | LEU | ILE | SER | PRO | MET | ||||
10 | THR | LEU | ASN | GLY | MET | ARG | ASP | PHE | TYR | LYS | ||||
11 | ASN | ASN | GLU | TYR | VAL | LYS | ASN | LEU | ASP | GLU | ||||
12 | LEU | THR | LEU | CYS | SER | ARG | HIS | ALA | GLY | ASN | ||||
13 | MET | ASN | PRO | ASP | ASN | ASP | LYS | ASN | SER | ASN | ||||
14 | TYR | LYS | TYR | PRO | ALA | VAL | TYR | ASP | TYR | ASN | ||||
15 | ASP | LYS | LYS | CYS | HIS | ILE | LEU | TYR | ILE | ALA | ||||
16 | ALA | PHE | ARG | ASN | ASN | GLY | PRO | ARG | TYR | CYS | ||||
17 | ASN | LYS | ASP | GLN | SER | LYS | ARG | ASN | SER | MET | ||||
18 | PHE | CYS | PHE | LYS | PRO | ALA | LYS | ASP | LYS | LEU | ||||
19 | PHE | GLU | ASN | TYR | THR | TYR | LEU | SER | LYS | ASN | ||||
20 | VAL | VAL | ASP | ASN | TRP | GLU | GLU | VAL | CYS | PRO | ||||
21 | ARG | LYS | ASN | LEU | GLU | ASN | ALA | LYS | PHE | GLY | ||||
22 | LEU | TRP | VAL | ASP | GLY | ASN | CYS | GLU | ASP | ILE | ||||
23 | PRO | HIS | VAL | ASN | GLU | PHE | SER | ALA | ASN | ASN | ||||
24 | ASP | LEU | GLU | CYS | ASN | LYS | LEU | VAL | PHE | GLU | ||||
25 | LEU | SER | ALA | SER | ASP | GLN | PRO | LYS | GLN | TYR | ||||
26 | GLU | GLN | HIS | LEU | THR | ASP | TYR | GLU | LYS | ILE | ||||
27 | LYS | GLU | GLY | PHE | LYS | ASN | LYS | ASN | ALA | SER | ||||
28 | MET | ILE | LYS | SER | ALA | PHE | LEU | PRO | THR | GLY | ||||
29 | ALA | PHE | LYS | ALA | ASP | ARG | TYR | LYS | SER | HIS | ||||
30 | GLY | LYS | GLY | TYR | ASN | TRP | GLY | ASN | TYR | ASN | ||||
31 | ARG | GLU | THR | GLN | LYS | CYS | GLU | ILE | PHE | ASN | ||||
32 | VAL | LYS | PRO | THR | CYS | LEU | ILE | ASN | ASN | SER | ||||
33 | SER | TYR | ILE | ALA | THR | THR | ALA | LEU | SER | HIS | ||||
34 | PRO | ILE | GLU | VAL | GLU |
sample_1: FVO PfAMA1, [U-100% 13C; U-100% 15N; U-80% 2H], 250 uM; D2O, [U-2H], 10%; sodium azide 0.01%; sodium phosphate 20 mM; arginine 50 mM; glutamic acid 50 mM; protease inhibitor cocktail 0.2%; H2O 90%
sample_2: FVO PfAMA1, [U-15N]-Lys; [U-80%] 2H, 80 uM; D2O, [U-100% 2H], 10%; sodium phosphate 20 mM; glutamic acid 50 mM; arginine 50 mM; protease inhibitor cocktail 0.2%; sodium azide 0.01%; H2O 90%
sample_conditions_1: ionic strength: 120 mM; pH: 6.8; pressure: 1 atm; temperature: 308 K
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
2D 1H-15N HSQC | sample_1 | isotropic | sample_conditions_1 |
3D HNCA | sample_1 | isotropic | sample_conditions_1 |
3D HN(CO)CA | sample_1 | isotropic | sample_conditions_1 |
3D HN(CA)CB | sample_1 | isotropic | sample_conditions_1 |
3D HN(COCA)CB | sample_1 | isotropic | sample_conditions_1 |
2D 1H-15N HSQC | sample_2 | isotropic | sample_conditions_1 |
TOPSPIN, Bruker Biospin - collection
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks